Long-Term Specified Drug Use-Results Survey in Patients With Pre-dialysis Chronic Kidney Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Bixalomer (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Astellas Pharma
- 21 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 28 Sep 2016 Status changed from not yet recruiting to recruiting.